Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Knapp

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
Gynecologic Oncology|February 1, 1994
Molecular cloning of differentially expressed genes in human epithelial ovarian cancerS C Mok, K K Wong, R K Chan, et al.
Cancer|November 15, 1995
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markersS J Skates, F J Xu, Y H Yu, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
Cancer|October 25, 1991
Coordinate elevation of serum markers in ovarian cancer but not in benign diseaseR C Bast, S Knauf, A Epenetos, et al.
Gynecologic Oncology|September 1, 1985
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinomaR C Bast, F P Siegal, C Runowicz, et al.
Gynecologic Oncology|July 1, 1989
Predictive factors for long-term survival in patients with advanced ovarian cancerK J Krag, G P Canellos, C T Griffiths, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Obstetrics and Gynecology|May 1, 1986
CA 125 serum levels correlated with second-look operations among ovarian cancer patientsJ S Berek, R C Knapp, G D Malkasian, et al.
Gynecologic Oncology|February 1, 1994
Molecular cloning of differentially expressed genes in human epithelial ovarian cancerS C Mok, K K Wong, R K Chan, et al.
Cancer|November 15, 1995
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markersS J Skates, F J Xu, Y H Yu, et al.
Obstetrics and Gynecology|November 1, 1984
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancerJ S Berek, R C Bast, A Lichtenstein, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
Cancer|October 25, 1991
Coordinate elevation of serum markers in ovarian cancer but not in benign diseaseR C Bast, S Knauf, A Epenetos, et al.
Gynecologic Oncology|September 1, 1985
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinomaR C Bast, F P Siegal, C Runowicz, et al.
Gynecologic Oncology|July 1, 1989
Predictive factors for long-term survival in patients with advanced ovarian cancerK J Krag, G P Canellos, C T Griffiths, et al.
Pageof 9